U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Congenital aniridia(AN)

MedGen UID:
1941
Concept ID:
C0003076
Congenital Abnormality
Synonyms: AN; Aniridia
SNOMED CT: Aniridia (69278003); Irideremia (69278003); Aplasia of iris (69278003); Congenital aniridia (69278003); Agenesis of iris (69278003); Congenital absence of iris (69278003)
 
Related genes: TRIM44, ELP4, WT1, PAX6
 
HPO: HP:0000526
Monarch Initiative: MONDO:0019172
OMIM®: 606985; 607108

Disease characteristics

Excerpted from the GeneReview: PAX6-Related Aniridia
PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ <74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral issues. [from GeneReviews]
Authors:
Mariya Moosajee  |  Melanie Hingorani  |  Anthony T Moore   view full author information

Additional description

From MedlinePlus Genetics
Aniridia is an eye disorder characterized by a complete or partial absence of the colored part of the eye (the iris). These iris abnormalities may cause the pupils to be abnormal or misshapen. Aniridia can cause reduction in the sharpness of vision (visual acuity) and increased sensitivity to light (photophobia).

Rarely, people with aniridia have behavioral problems, developmental delay, and problems detecting odors.

People with aniridia can also have other eye problems. Increased pressure in the eye (glaucoma) typically appears in late childhood or early adolescence. Clouding of the lens of the eye (cataracts), occur in 50 percent to 85 percent of people with aniridia. In about 10 percent of affected people, the structures that carry information from the eyes to the brain (optic nerves) are underdeveloped. Individuals with aniridia may also have involuntary eye movements (nystagmus) or underdevelopment of the region at the back of the eye responsible for sharp central vision (foveal hypoplasia). Many of these eye problems contribute to progressive vision loss in affected individuals. The severity of symptoms is typically the same in both eyes.  https://medlineplus.gov/genetics/condition/aniridia

Conditions with this feature

Focal dermal hypoplasia
MedGen UID:
42055
Concept ID:
C0016395
Disease or Syndrome
Focal dermal hypoplasia is a multisystem disorder characterized primarily by involvement of the skin, skeletal system, eyes, and face. Skin manifestations present at birth include atrophic and hypoplastic areas of skin; cutis aplasia; fat nodules in the dermis manifesting as soft, yellow-pink cutaneous nodules; and pigmentary changes. Verrucoid papillomas of the skin and mucous membranes may appear later. The nails can be ridged, dysplastic, or hypoplastic; hair can be sparse or absent. Limb malformations include oligo-/syndactyly and split hand/foot. Developmental abnormalities of the eye can include anophthalmia/microphthalmia, iris and chorioretinal coloboma, and lacrimal duct abnormalities. Craniofacial findings can include facial asymmetry, notched alae nasi, cleft lip and palate, and pointed chin. Occasional findings include dental anomalies, abdominal wall defects, diaphragmatic hernia, and renal anomalies. Psychomotor development is usually normal; some individuals have cognitive impairment.
11p partial monosomy syndrome
MedGen UID:
64512
Concept ID:
C0206115
Disease or Syndrome
PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ <74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.
Aniridia 1
MedGen UID:
576337
Concept ID:
C0344542
Congenital Abnormality
PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ <74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.
Aniridia 2
MedGen UID:
138010
Concept ID:
C0344543
Congenital Abnormality
Gillespie syndrome
MedGen UID:
96563
Concept ID:
C0431401
Disease or Syndrome
Gillespie syndrome (GLSP) is usually diagnosed in the first year of life by the presence of fixed dilated pupils in a hypotonic infant. Affected individuals have a characteristic form of iris hypoplasia in which the pupillary border of the iris exhibits a scalloped or 'festooned' edge, with iris strands extending onto the anterior lens surface at regular intervals. The key extraocular features of Gillespie syndrome are congenital hypotonia, progressive cerebellar hypoplasia, and ataxia, as well as variable cognitive impairment that is usually mild (summary by Gerber et al., 2016 and McEntagart et al., 2016).
Congenital primary aphakia
MedGen UID:
339935
Concept ID:
C1853230
Congenital Abnormality
Anterior segment dysgeneses are a heterogeneous group of developmental disorders affecting the anterior segment of the eye, including the cornea, iris, lens, trabecular meshwork, and Schlemm canal. The clinical features of ASGD include iris hypoplasia, an enlarged or reduced corneal diameter, corneal vascularization and opacity, posterior embryotoxon, corectopia, polycoria, an abnormal iridocorneal angle, ectopia lentis, and anterior synechiae between the iris and posterior corneal surface (summary by Cheong et al., 2016). Anterior segment dysgenesis is sometimes divided into subtypes, including aniridia (see 106210), Axenfeld and Rieger anomalies, iridogoniodysgenesis, Peters anomaly, and posterior embryotoxon (Gould and John, 2002). Some patients with ASGD2 have been reported with a congenital primary aphakia subtype. Congenital primary aphakia is a rare developmental disorder characterized by absence of the lens, the development of which is normally induced during the fourth to fifth week of human embryogenesis. This original failure leads, in turn, to complete aplasia of the anterior segment of the eye, which is the diagnostic histologic criterion for CPAK. In contrast, in secondary aphakia, lens induction occurs and the lens vesicle develops to some degree, but is progressively resorbed perinatally, resulting in less severe ocular defects (summary by Valleix et al., 2006).
Aniridia-renal agenesis-psychomotor retardation syndrome
MedGen UID:
347952
Concept ID:
C1859782
Disease or Syndrome
An extremely rare syndrome reported in two siblings of non consanguineous parents that is characterized by the association of ocular abnormalities (partial aniridia, congenital glaucoma, telecanthus) with frontal bossing, hypertelorism, unilateral renal agenesis and mild psychomotor delay. There have been no further descriptions in the literature since 1974.
Aniridia, microcornea, and spontaneously Reabsorbed cataract
MedGen UID:
350777
Concept ID:
C1862867
Disease or Syndrome
Aniridia, microcornea, and spontaneously reabsorbed cataract represents a complex phenotype of ocular malformation. Bilateral microphathalmia, persistent fetal vasculature, and secondary glaucoma have also been observed (Marakhonov et al., 2020).
Aniridia-absent patella syndrome
MedGen UID:
400149
Concept ID:
C1862868
Disease or Syndrome
A syndrome described in three members of a family (a boy, his father and his paternal grandmother) with the association of aniridia and patella aplasia or hypoplasia. The grandmother also had bilateral cataracts and glaucoma. There have been no further descriptions in the literature since 1975.
Osteocraniostenosis
MedGen UID:
356331
Concept ID:
C1865639
Disease or Syndrome
Gracile bone dysplasia (GCLEB) is a perinatally lethal condition characterized by gracile bones with thin diaphyses, premature closure of basal cranial sutures, and microphthalmia (summary by Unger et al., 2013).
Wilms tumor, aniridia, genitourinary anomalies, intellectual disability, and obesity syndrome
MedGen UID:
382718
Concept ID:
C2675904
Disease or Syndrome
For a detailed discussion of the WAGR syndrome, see 194072. In a subgroup of individuals with the WAGR syndrome, obesity develops. The phenotype in this subset is associated with haploinsufficiency for the BDNF gene.
Axenfeld-Rieger syndrome type 1
MedGen UID:
811487
Concept ID:
C3714873
Disease or Syndrome
Axenfeld-Rieger syndrome is an autosomal dominant disorder of morphogenesis that results in abnormal development of the anterior segment of the eye, and results in blindness from glaucoma in approximately 50% of affected individuals (Fitch and Kaback, 1978). Systemic anomalies are associated, including dental hypoplasia, failure of involution of periumbilical skin, and maxillary hypoplasia (Alkemade, 1969). Genetic Heterogeneity of Axenfeld-Rieger Syndrome Linkage studies indicate that a second type of Axenfeld-Rieger syndrome maps to chromosome 13q14 (RIEG2; 601499). A third form of Axenfeld-Rieger syndrome (RIEG3; 602482) is caused by mutation in the FOXC1 gene (601090) on chromosome 6p25. See 109120 for a form of Axenfeld-Rieger syndrome associated with partially absent eye muscles, hydrocephalus, and skeletal abnormalities.
Aniridia 3
MedGen UID:
934662
Concept ID:
C4310695
Congenital Abnormality
Any isolated aniridia in which the cause of the disease is a mutation in the TRIM44 gene.
Chromosome 11p13 deletion syndrome, distal
MedGen UID:
935014
Concept ID:
C4311047
Disease or Syndrome
Lactic aciduria due to D-lactic acid
MedGen UID:
1679270
Concept ID:
C5193006
Disease or Syndrome
D-lactic aciduria is characterized by elevated D-lactate in plasma and urine. Patients show elevated serum uric acid concentrations and low urinary uric acid levels, due to reduced renal clearance of uric acid, and affected adults may experience episodes of gouty arthropathy (Drabkin et al., 2019). For a discussion of genetic heterogeneity of serum uric acid concentration quantitative trait loci, see UAQTL1 (138900).

Professional guidelines

PubMed

Fries FN, Moslemani K, Utheim TP, Seitz B, Käsmann-Kellner B, Lagali NS
Br J Ophthalmol 2023 Dec 18;108(1):30-36. doi: 10.1136/bjo-2021-320774. PMID: 36517210Free PMC Article
Vasilyeva TA, Marakhonov AV, Voskresenskaya AA, Kadyshev VV, Käsmann-Kellner B, Sukhanova NV, Katargina LA, Kutsev SI, Zinchenko RA
J Med Genet 2021 Apr;58(4):270-274. Epub 2020 May 28 doi: 10.1136/jmedgenet-2019-106172. PMID: 32467297
Neethirajan G, Solomon A, Krishnadas SR, Vijayalakshmi P, Sundaresan P
Indian J Pediatr 2009 May;76(5):513-7. Epub 2009 Apr 23 doi: 10.1007/s12098-009-0075-4. PMID: 19390808

Recent clinical studies

Etiology

van Velthoven AJH, Utheim TP, Notara M, Bremond-Gignac D, Figueiredo FC, Skottman H, Aberdam D, Daniels JT, Ferrari G, Grupcheva C, Koppen C, Parekh M, Ritter T, Romano V, Ferrari S, Cursiefen C, Lagali N, LaPointe VLS, Dickman MM
Surv Ophthalmol 2023 Sep-Oct;68(5):940-956. Epub 2023 May 4 doi: 10.1016/j.survophthal.2023.04.003. PMID: 37146692
Alafaleq M, Sordello L, Bremond-Gignac D
Am J Ophthalmol 2023 Mar;247:145-151. Epub 2022 Nov 11 doi: 10.1016/j.ajo.2022.11.003. PMID: 36375586
Jacobson A, Mian SI, Bohnsack BL
BMC Ophthalmol 2022 May 25;22(1):235. doi: 10.1186/s12886-022-02460-5. PMID: 35614435Free PMC Article
D'Oria F, Barraquer R, Alio JL
Arch Soc Esp Oftalmol (Engl Ed) 2021 Nov;96 Suppl 1:38-51. Epub 2021 Jun 12 doi: 10.1016/j.oftale.2020.12.008. PMID: 34836587
Landsend ECS, Lagali N, Utheim TP
Surv Ophthalmol 2021 Nov-Dec;66(6):1031-1050. Epub 2021 Mar 4 doi: 10.1016/j.survophthal.2021.02.011. PMID: 33675823

Diagnosis

Alafaleq M, Sordello L, Bremond-Gignac D
Am J Ophthalmol 2023 Mar;247:145-151. Epub 2022 Nov 11 doi: 10.1016/j.ajo.2022.11.003. PMID: 36375586
Daruich A, Duncan M, Robert MP, Lagali N, Semina EV, Aberdam D, Ferrari S, Romano V, des Roziers CB, Benkortebi R, De Vergnes N, Polak M, Chiambaretta F, Nischal KK, Behar-Cohen F, Valleix S, Bremond-Gignac D
Prog Retin Eye Res 2023 Jul;95:101133. Epub 2022 Oct 22 doi: 10.1016/j.preteyeres.2022.101133. PMID: 36280537
Tibrewal S, Ratna R, Gour A, Agarkar S, Dubey S, Ganesh S, Kekunnaya R, Sangwan V, Liu Y, Vanita V
Indian J Ophthalmol 2022 Jul;70(7):2280-2292. doi: 10.4103/ijo.IJO_2255_21. PMID: 35791108Free PMC Article
Casas-Llera P, Ruiz-Casas D, Alió JL
Arch Soc Esp Oftalmol (Engl Ed) 2021 Nov;96 Suppl 1:60-67. Epub 2021 Jun 4 doi: 10.1016/j.oftale.2020.11.006. PMID: 34836590
Ihnatko R, Eden U, Fagerholm P, Lagali N
Ocul Surf 2016 Apr;14(2):196-206. Epub 2015 Dec 29 doi: 10.1016/j.jtos.2015.10.003. PMID: 26738798

Therapy

Romano D, Bremond-Gignac D, Barbany M, Rahman A, Mauring L, Semeraro F, Cursiefen C, Lagali N, Romano V
Surv Ophthalmol 2023 Jul-Aug;68(4):794-808. Epub 2022 Nov 12 doi: 10.1016/j.survophthal.2022.11.001. PMID: 36379301
Vasilyeva TA, Marakhonov AV, Sukhanova NV, Kutsev SI, Zinchenko RA
Genes (Basel) 2020 Jul 17;11(7) doi: 10.3390/genes11070812. PMID: 32708836Free PMC Article
Soyugelen Demirok G, Ekşioğlu Ü, Yakın M, Kaderli A, Kaderli ST, Örnek F
Turk J Ophthalmol 2019 Sep 3;49(4):183-187. doi: 10.4274/tjo.galenos.2019.07348. PMID: 31486604Free PMC Article
Qiu X, Ji Y, Zheng T, Lu Y
Acta Ophthalmol 2016 Aug;94(5):e340-4. Epub 2015 Dec 9 doi: 10.1111/aos.12923. PMID: 26648453
Ihnatko R, Edén U, Lagali N, Dellby A, Fagerholm P
J Proteomics 2013 Dec 6;94:78-88. Epub 2013 Sep 21 doi: 10.1016/j.jprot.2013.09.003. PMID: 24061003

Prognosis

Pedersen HR, Gilson SJ, Landsend ECS, Utheim ØA, Utheim TP, Baraas RC
Invest Ophthalmol Vis Sci 2023 Apr 3;64(4):18. doi: 10.1167/iovs.64.4.18. PMID: 37067366Free PMC Article
Daruich A, Duncan M, Robert MP, Lagali N, Semina EV, Aberdam D, Ferrari S, Romano V, des Roziers CB, Benkortebi R, De Vergnes N, Polak M, Chiambaretta F, Nischal KK, Behar-Cohen F, Valleix S, Bremond-Gignac D
Prog Retin Eye Res 2023 Jul;95:101133. Epub 2022 Oct 22 doi: 10.1016/j.preteyeres.2022.101133. PMID: 36280537
Tibrewal S, Ratna R, Gour A, Agarkar S, Dubey S, Ganesh S, Kekunnaya R, Sangwan V, Liu Y, Vanita V
Indian J Ophthalmol 2022 Jul;70(7):2280-2292. doi: 10.4103/ijo.IJO_2255_21. PMID: 35791108Free PMC Article
Jacobson A, Mian SI, Bohnsack BL
BMC Ophthalmol 2022 May 25;22(1):235. doi: 10.1186/s12886-022-02460-5. PMID: 35614435Free PMC Article
Landsend ECS, Lagali N, Utheim TP
Surv Ophthalmol 2021 Nov-Dec;66(6):1031-1050. Epub 2021 Mar 4 doi: 10.1016/j.survophthal.2021.02.011. PMID: 33675823

Clinical prediction guides

Pedersen HR, Gilson SJ, Landsend ECS, Utheim ØA, Utheim TP, Baraas RC
Invest Ophthalmol Vis Sci 2023 Apr 3;64(4):18. doi: 10.1167/iovs.64.4.18. PMID: 37067366Free PMC Article
Fries FN, Moslemani K, Utheim TP, Seitz B, Käsmann-Kellner B, Lagali NS
Br J Ophthalmol 2023 Dec 18;108(1):30-36. doi: 10.1136/bjo-2021-320774. PMID: 36517210Free PMC Article
Pedersen HR, Baraas RC, Landsend ECS, Utheim ØA, Utheim TP, Gilson SJ, Neitz M
Invest Ophthalmol Vis Sci 2020 May 11;61(5):14. doi: 10.1167/iovs.61.5.14. PMID: 32396632Free PMC Article
Ihnatko R, Eden U, Fagerholm P, Lagali N
Ocul Surf 2016 Apr;14(2):196-206. Epub 2015 Dec 29 doi: 10.1016/j.jtos.2015.10.003. PMID: 26738798
Chang JW, Kim JH, Kim SJ, Yu YS
Korean J Ophthalmol 2014 Dec;28(6):479-85. Epub 2014 Nov 19 doi: 10.3341/kjo.2014.28.6.479. PMID: 25435751Free PMC Article

Recent systematic reviews

Romano D, Bremond-Gignac D, Barbany M, Rahman A, Mauring L, Semeraro F, Cursiefen C, Lagali N, Romano V
Surv Ophthalmol 2023 Jul-Aug;68(4):794-808. Epub 2022 Nov 12 doi: 10.1016/j.survophthal.2022.11.001. PMID: 36379301

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...